Salient is an excellent design with a fresh approach for the ever-changing Web. Integrated with Gantry 5, it is infinitely customizable, incredibly powerful, and remarkably simple.


Understanding Vaping: the pleasure principle

This free to attend dialogue, hosted by Vapourtrails TV, took place from 1400-1700, on Thursday 2nd November, at Crook Hall & Gardens, Frankland Lane, Sidegate, Durham, DH1 5SZ.

Members of the panel included:

Professor Gerry Stimson Chair
Knowledge•Action•Change, UK
Prof Gerry Stimson is a public health social scientist, with over 40 years’ experience of research and advocacy. He was one of the founders of drugs harm reduction in the 1980s and helped develop and evaluate harm reduction in the UK as a response to HIV/AIDS. He has advised the UK Government, World Health Organization, UNAIDS, UNODC, World Bank and numerous governments on issues relating to drugs, HIV infection and AIDS, and alcohol. He is an advocate for tobacco harm reduction as a key public health strategy for reducing smoking related harms. He was a member of the UK National Institute for Health and Clinical Excellence guidelines group on tobacco harm reduction, and is a member of the British Standards Institute working group on e-cigarette standards. He helps organise the Global Forum on Nicotine conference. He has published over 220 scientific publications and several books. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London, and recent past Editor of the International Journal of Drug Policy. He was Executive Director of the International Harm Reduction Association from 2004 to 2010.
David Dorn
New Nicotine Alliance and VTTV, UK
Vaper of over five years who presents and researches on ecigs for one of the most popular ecig-centric televisual services on the Internet.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Dr Richard Holliday
Newcastle University, UK
Richard Holliday is a Speciality Registrar (StR) in Restorative Dentistry and NIHR Doctoral Research Fellow at Newcastle University. Richard’s research interests are focused on periodontal diseases, particularly risk factors, and he is currently completing his PhD on ‘e-cigarettes as a smoking cessation or harm reduction tool for patients with periodontitis’. The main body of this work is a feasibility randomised controlled trial of 80 smokers with periodontitis. Additional projects include surveys of tobacco education in UK dental schools, surveys of practitioner opinions and in vitro analysis.
Jacques le Houezec
Jacques le Houezec
Président, #SOVAPE, France
Trained neuroscientist in Paris (PhD in 1988) who spent 2 years as a post-doctoral fellow in Clinical Pharmacology & Experimental Therapeutics at the University of California. After 6 years of research in La Salpêtrière Hospital (Paris), and teaching at Paris V and Paris VII Universities, he became a freelance consultant for the pharmaceutical industry and the public sector (training smoking cessation specialists, and writing monthly scientific digests for them). He is a Charter Member of SRNT and was part of the core group who founded SRNT Europe. He participated in the Steering Committee of the WHO Europe Partnership Project to reduce Tobacco Dependence (1991-2001), and was also on the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCHENIR) expert group on smokeless tobacco (2006-2008). He is also Honorary Lecturer, UK Centre for Tobacco Control Studies, University of Nottingham, England, and manager of the SRNT & SSA website dedicated to tobacco dependence treatment.
Frances Thirlway
University of York, UK
Frances is a Research Fellow at the University of York working on health, class and culture; her interest in e-cigarettes is mainly in relation to their potential to address health inequalities in high-smoking deprived areas. She recently received funding from Cancer Research UK for her project entitled ‘Electronic cigarettes, health inequalities and smoking cessation: a community study of take-up and market evolution in two high smoking prevalence areas of the North of England’. The project runs from April 2017 to March 2019 and involves fieldwork in County Durham and North Manchester, getting to know smokers, quitters and electronic cigarette users as well as e-cigarette vendors. Frances is bilingual in French and hopes to extend her research to the ex-mining areas of Northern France. She recently attended Vapexpo in Paris and talked to e-cigarette users and vendors in the towns of Douai and Valenciennes.

Some questions the panel addressed are:

  • Why do people vape?
  • What is the ‘pleasure principle’?
  • Is nicotine dependence a problem, and if so for whom?